According to Gen Consulting Company, the global bioanalytical testing service market is projected to reach USD 5,012 million, recording a CAGR of approximately 7.8 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global bioanalytical testing service market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the bioanalytical testing service industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the molecule type, workflow, test type, and region. The global market for bioanalytical testing service can be segmented by molecule type: large molecules, small molecules. Globally, the small molecules segment made up the largest share of the bioanalytical testing service market. Bioanalytical testing service market is further segmented by workflow: sample preparation, sample analysis, others. Based on test type, the bioanalytical testing service market is segmented into: absorption, distribution, metabolism, and excretion (ADME), bioavailability and bioequivalence studies, pharmacodynamics (PD), pharmacokinetics (PK), others. On the basis of region, the bioanalytical testing service market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

By molecule type:
– large molecules
– small molecules

By workflow:
– sample preparation
– sample analysis
– others

By test type:
– absorption, distribution, metabolism, and excretion (ADME)
– bioavailability and bioequivalence studies
– pharmacodynamics (PD)
– pharmacokinetics (PK)
– others

By region:
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America

The report also provides a detailed analysis of several leading bioanalytical testing service market vendors that include Almac Group Limited, Charles River Laboratories, Inc., Eurofins Scientific SE, Frontage Laboratories, Inc, ICON plc, Intertek Group plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), Medpace Holdings, Inc., PPD Inc. (Thermo Fisher Scientific Inc.), SGS SA, Syneos Health, Inc., WuXi AppTec Co., Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global bioanalytical testing service market.
– To classify and forecast the global bioanalytical testing service market based on molecule type, workflow, test type, region.
– To identify drivers and challenges for the global bioanalytical testing service market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global bioanalytical testing service market.
– To identify and analyze the profile of leading players operating in the global bioanalytical testing service market.

Why Choose This Report
– Gain a reliable outlook of the global bioanalytical testing service market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.